Robert Saddawi-Konefka

13PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 17, 2026
Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC.

|Sep 29, 2025
In vivo CRISPR screening in head and neck cancer reveals Uchl5 as an immunotherapy target.

Cong Fu, Robert Saddawi-Konefka, Jordan M Chinai

|Sep 01, 2025
Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma.

Binbin Wang, Robert Saddawi-Konefka, Lauren M Clubb

|Jul 17, 2025
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy.

Robert Saddawi-Konefka, Riyam Al Msari, Shiqi Tang

|Jul 14, 2025
Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma.

Cheyanne K Shinn, Robert Saddawi-Konefka, Catherina L Salanga

|Jan 22, 2025
The XCL1-XCR1 axis supports intestinal tissue residency and antitumor immunity.

Amir Ferry, Kianoosh M Mempel, Alexander Monell

Pageof 3

Frequent Collaborators

6 joint publications

J Silvio Gutkind

4 joint publications

Shiruyeh Schokrpur

3 joint publications

Farhoud Faraji

2 joint publications

Sarah M Luna